Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial
February 17, 2026
Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS
2 min read
False
Advertisement
Research News
First Preclinical Development Candidate for Nucleome Therapeutics
January 19, 2026
First-in-class monoclonal antibody agonist program for inflammation
2 min read
The Post-Pandemic Evolution of Antiviral Research
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
New Approach Methodologies: Why the Future of Drug Development Must Be Human
By Hayley Gooding
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
Promising Data For Off-the-Shelf Gene-edited Cell Therapy
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
This Week’s Biopharma News: New Pharma Legislation in Europe
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
Outsmarting Cancer: The “Trojan Horse” of Gene Therapy
By Stephanie Vine
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
This Week’s CGT News: Advancing Mitochondrial Therapy
December 2, 2025
Our latest news roundup reports on a partnership to bring cell and gene therapies to underserved communities in India, a new biotech using AI to improve gene editing, and more
4 min read
How Tap Water Sparked a Breakthrough in Ion-Assisted Chromatography
November 14, 2025
Southwest Research Institute chemists share how a chance mishap with deionized water led to a method that may accelerate the purification of active drug ingredients
7 min read
Intranasal H5 Vaccine Sparks Broad Immune Response Across Diverse Avian Flu Strains
November 13, 2025
Phase I trial finds intranasal, adjuvanted recombinant H5 influenza vaccine primes strong mucosal and systemic immunity – subsequent injection boost yields cross-clade protection against multiple H5N1 viruses.
1 min read
